CORE--GERIATRIC PSYCHOPHARMACOLOGY

$0P30FY2002MHNIH

University Of Pittsburgh At Pittsburgh, Pittsburgh PA

Investigators

Linked publications & trials

Paper 28336265 Paper 27438687 Paper 26058663 Paper 25689482 Paper 25298616 Paper 24353128 Paper 23759435 Paper 23738992 Paper 23567441 Paper 23131524 Paper 22767341 Paper 22522377 Paper 21946013 Paper 21799066 Paper 21727232 Paper 21329911 Paper 21105282 Paper 20974064 Paper 20963751 Paper 20957693 Paper 20122047 Paper 20082348 Paper 20077972 Paper 19946460 Paper 19910882 Paper 19843655 Paper 19776306 Paper 19719787 Paper 19528195 Paper 19401957 Paper 19087899 Paper 19001356 Paper 18978251 Paper 18790876 Paper 18771484 Paper 18580591 Paper 18547203 Paper 18450930 Paper 18394922 Paper 18310550 Paper 18239196 Paper 18172910 Paper 17984481 Paper 17921032 Paper 17767673 Paper 17629727 Paper 17514852 Paper 17502629 Paper 17463353 Paper 17453654 Paper 17440121 Paper 17401042 Paper 17336663 Paper 17321595 Paper 17299808 Paper 17272739 Paper 17233689 Paper 17205639 Paper 17192115 Paper 17188896 Paper 17141356 Paper 17097277 Paper 17096459 Paper 17092516 Paper 17068318 Paper 17014605 Paper 16968764 Paper 16968759 Paper 16943177 Paper 16934334 Paper 16927582 Paper 16924019 Paper 16879079 Paper 16861369 Paper 16814626 Paper 16768570 Paper 16741209 Paper 16731725 Paper 16684729 Paper 16670246 Paper 16669849 Paper 16649835 Paper 16642541 Paper 16633138 Paper 16585663 Paper 16583267 Paper 16566618 Paper 16540613 Paper 16503306 Paper 16473996 Paper 16463385 Paper 16461855 Paper 16389196 Paper 16325738 Paper 16325731 Paper 16296562 Paper 16275844 Paper 16252293 Paper 16172176 Paper 16166411

Abstract

This Core focuses on antidepressant studies and is particularly concerned with the assay of nortriptyline and paroxetine platelet 5-HT reuptake interrupted by the use of antidepressant medication, including a double- blind study of paroxetine, a potent innovative serotonin reuptake inhibitor versus the more generally used nortriptyline. The goal of the study is to document pharmacokinetic changes in elderly adults. one primary goal of the present Core is to provide support for other cores and relevant projects of the investigators focused on pharmacokinetic/pharmacodynamic assessments, and to provide relevant instruction for students and area nursing homes, in vivo (phenotyping) and in vitro (drug metabolic assays) studies of cytochrome P450 function, an enzyme responsible for metabolism of significant antidepressants.

View original record on NIH RePORTER →